Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Paraganglioma × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Neoplasms 29 Breast Neoplasms 24 Lung Neoplasms 20 Colorectal Neoplasms 16 Prostatic Neoplasms 13 Head and Neck Neoplasms 10 Ovarian Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 8 Melanoma 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Glioma 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplastic Cells, Circulating 5 Multiple Myeloma 5 Endometrial Neoplasms 5 Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Neoplasm, Residual 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Hematologic Neoplasms 4 Carcinoma, Renal Cell 4 Thrombosis 3 Skin Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3

Interventions

gallium Ga 68 dotatate 4 lutetium Lu 177 dotatate 2 belzutifan 2 Fluorodeoxyglucose F18 2 olaparib 1 fludarabine phosphate 1 Specimen Handling 1 Phenoxybenzamine 1 Magnetic Resonance Spectroscopy 1 Interleukin-13 1 Genetic Testing 1 Cyclophosphamide 1 Blood Specimen Collection 1 Biopsy 1 3-fluorobenzylguanidine 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06444607 2024-11-21

HEPHESTOS

Radboud University Medical Center

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡